- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01420406
Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status
Impact of Daily Feeding of Food Sources of Cryptoxanthin (CX) and Beta-carotene (BC) on Plasma and Breast Milk Concentrations of CX, BC, and Retinol (VA) in Lactating Women With Marginal Vitamin A Status
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The specific aim is to compare the effects of orange-fleshed sweet potatoes and tangerines compared to white-fleshed sweet potatoes and vitamin A as retinyl palmitate on blood and breast milk cryptoxanthin (CX), beta-carotene (BC), and vitamin A (VA) concentrations by randomly assigning lactating Bangladeshi women to one of four treatment groups for 6 days/week for 3 weeks.
The investigators will also compare the relative vitamin A (VA) value of BC and CX from food sources by comparing the mean change in breast milk retinol concentrations of the groups that receive tangerines (CX) or orange-fleshed sweet potatoes (BC) with the mean change in breast milk retinol of the group that receives retinyl palmitate.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dhaka, Bangladesh
- International Centre for Diarrhoeal Disease Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy women in Dhaka, Bangladesh
- Lactating women in their 2nd or 3rd month of lactation who are planning to breast-feed at least 6 months
- Breast-feeding only one infant
- Age range 18 to 45 years
- Not pregnant
- Serum retinol concentrations >0.70 umol/L and <1.10 umol/L
- Normal concentrations of CRP (<10 mg/L)
- At least one arm vein deemed adequate for blood collection, as evaluated by a screening nurse.
- Willing to consume the test foods daily 6 d/wk for one month
Exclusion Criteria:
- Health status is not compatible with the inclusion criteria, such as screening blood chemistries indicative of vitamin A deficiency.
- Severe anemia (Hb <9 mg/dL)
- Current pregnancy
- Must not have known allergy to citrus fruit (tangerines or mandarin oranges) or sweet potatoes
- Must have no obvious psychological or sociological problems-such as alcoholism, drug abuse, or severe and acute mental illness that would influence their ability to sign an inform consent agreement or to participate in study duties and activities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: 0 mg retinol
0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule
|
0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule
|
Experimental: 12 mg BC
12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule.
|
12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule
|
Experimental: 6 mg of CX
6 mg of CX as tangerines and a corn oil capsule
|
6 mg of CX as tangerines and a corn oil capsule
|
Experimental: 1.0 mg RAE
1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes
|
1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in carotenoids in serum and breast milk
Time Frame: 1 and 3 weeks
|
We will measure serum and breast milk beta-carotene, beta-cryptoxanthin, other carotenoids, and vitamins A and E.
|
1 and 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Dark adaptation
Time Frame: 1 and 3 weeks
|
Dark adaptation will be measured by the pupillary threshold (PT) test on the first and 3rd weeks of the study.
|
1 and 3 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Betty J Burri, PhD, WHNRC
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WHNRC 200816672
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Deficiency
-
SourseCitruslabsActive, not recruitingMood | Energy Supply; Deficiency | B12 Deficiency VitaminUnited States
-
Boston UniversityCompletedVitamin D Deficiency | Vitamin E Deficiency | Hypovitaminosis AUnited States
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitationIron Deficiency (Without Anemia) | B12 Deficiency VitaminUnited Kingdom
-
Kansas State UniversityNational Institute for Medical Research, Tanzania; United States Department... and other collaboratorsCompletedAnemia, Iron-Deficiency | Deficiency, Vitamin A
-
Newcastle UniversityBill and Melinda Gates Foundation; Institute of Nutrition of Central America... and other collaboratorsUnknownVitamin A Deficiency | Vitamin A Toxicity | Hypervitaminosis AGuatemala, United Kingdom
-
Fatih Sultan Mehmet Training and Research HospitalActive, not recruitingVitamin D Deficiency | Lipedema | B12 Deficiency VitaminTurkey
-
Nottingham University Hospitals NHS TrustNorthern Care Alliance NHS Foundation Trust; Barts & The London NHS Trust; University... and other collaboratorsNot yet recruitingParesthesia | Neurologic Symptoms | B12 Deficiency Vitamin | Nitrous Oxide Abuse | Subacute Combined Cord Degeneration
-
University of Wisconsin, MadisonNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedVitamin A Deficiency | Vitamin A ToxicityUnited States
-
University of California, DavisPenn State University; University of Ghana; Newcastle University; Helen Keller...CompletedAnemia | Dietary Habits | Iron Deficiency | Vitamin A Deficiency | Vitamin B 12 Deficiency | Folate Deficiency | Zinc DeficiencyGhana
Clinical Trials on 0 mg retinol activity equivalents
-
RECORDATI GROUPCompletedNeurogenic Detrusor OveractivityCzechia, France, Poland, Portugal
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; United States Agency for International Development... and other collaboratorsCompletedVitamin A Deficiency | Mortality Through Six Months of AgeBangladesh
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedHypogonadismUnited States
-
Columbia UniversityNational Institute on Aging (NIA)Active, not recruitingInflammation | Memory LossUnited States
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Weight Gain | Food PreferencesUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Otsuka Pharmaceutical Co., Ltd.TerminatedAgitation Associated With Dementia of the Alzheimer's TypeJapan
-
Centre hospitalier de l'Université de Montréal...Active, not recruiting
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...Completed